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Lung Autotransplantation Technique in the Treatment for
Central Lung Cancer of Upper Lobe
Feng Jiang, MD, Lin Xu, MD, Fang-liang Yuan, BS, Jian-feng Huang, MD, and Xin-xin Lu, MS
Aim: To assess the feasibility and benefit of lung autotransplanta-
tion technique in surgical treatment for central lung cancer of upper
lobe which could not tolerate pneumonectomy.
Methods: From August 2000 to August 2006 seven patients, who
were proved to be malignant pathologically through fiber-bronchoscope
before operation and could not tolerate pneumonectomy, underwent
lung autotransplantations. Double-sleeve resection of the right upper
and middle bilobectomy (or left upper lobectomy) and involved pul-
monary artery was performed firstly. Because the length of resected
bronchus or pulmonary artery involved by tumor was too long to
perform tension-free anastomosis, we transplanted the inferior pulmo-
nary vein to the proximal stump of the superior pulmonary vein. The
bronchus and pulmonary artery were anastomosed in turn. Then radical
hilar and mediastinal lymphadenectomy was performed.
Results: Until August 2006, among the seven patients who under-
went lung autotransplantations, five patients had been free of tumor
recurrence for 2 to 73 months with good quality of life. Radioisotope
scanning of the replanted lobe of one patient revealed normal
perfusion 6 years postoperatively. One patient received resection of
the replanted lobe because of pulmonary vein thrombus on the
second day after transplantation, and died of respiratory failure
caused by pulmonary relapse on 15th month postoperatively. An-
other patient died of brain metastases 31 months postoperatively. No
anastomotic stoma fistula occurred in these seven patients.
Conclusion: Lung autotransplantation is an alternative technique for
pulmonary preservation for patients with centrally placed tumor of
the upper lobe, whose pulmonary function is too poor to undergo
pneumonectomy.
Key Words: Central lung cancer, Lung autotransplantation, Pneu-
monectomy, Anastomotic fistula.
(J Thorac Oncol. 2008;3: 609–611)
Lung cancer occurs in epidemic proportions around theworld and continues to increase as the common cause of
solid-tumor cancer death in both men and women in the
United States.1 Small-cell lung cancer is generally managed
with nonsurgical treatment, whereas non-small cell lung can-
cer (NSCLC) confined to the lung is best managed with
surgical resection. As we know surgical treatment of central
NSCLC is always troublesome. Some patients suffered of
central NSCLC, whose pulmonary function is too poor to
tolerate pneumonectomy, have to resign surgical treatment.
Bronchovascular double sleeve lobectomy has proved to be a
satisfactory technique in the treatment of centrally placed
tumor of the upper lobe, because this lung-saving operation is
safer than pneumonectomy and is equally curative.2 But if the
tumor involves the bronchus and/or pulmonary artery exten-
sively, it is hard to perform bronchovascular double sleeve
lobectomy. Under this circumstance, lung autotransplanta-
tion, an alternative surgical technique for pulmonary preser-
vation and complete removal of the tumor, may be a good
surgical treatment. A retrospective study of lung autotrans-
plantations in our hospital is reported.
PATIENTS AND METHODS
Clinical Data of Lung Autotransplantation
From August 2000 to August 2006, seven patients
whose pulmonary function is too poor to tolerate pneumo-
nectomy received lung autotransplantations in our hospital.
The mean age of the seven patients (six males, one female)
was 55  9.8 years (range from 38 to 67 years old). Com-
puted tomography scan of the chests revealed central right or
left lung masses (Figure 1). The tumor of each patient was
proved to be malignant pathologically through fiber broncho-
scope before operation. Postoperative adjuvant chemotherapy
was administered to all these seven patients. The mean
number of adjuvant chemotherapy courses was 3.6 (range
2–4). The related clinical data of these seven patients was
listed in Table 1.
Surgical Technique of Lung
Autotransplantation
Sleeve resection of the right upper and middle bilobec-
tomy or left upper lobectomy was performed first. The asso-
ciated and involved pulmonary artery was resected, if neces-
sary. When the need for vascular resection was recognized,
intravenous heparin at 1 mg/kg was administered. After
excision, the gap between the proximal and distal airway
and/or pulmonary artery could not be bridged because of a
tethering effect by the inferior pulmonary vein. The lower
pulmonary vein was divided in the pericardium and the
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isolated lower lobe specimen was flushed with heparin solu-
tion (12,500 U/500 mL normal saline, at 20°C). About 500
mL of heparin solution was used to flush the inferior lobar
vein until the solution flowed out from the pulmonary artery
was clear. Then the inferior pulmonary vein was anastomosed
into the proximal stump of the upper lobar vein, but this
suture was not tied to allow future venting. The bronchus and
pulmonary artery were anastomosed in turn. The arterial
clamps were removed with the venous anastomosis open to
remove residual air, and then the venous suture line was tied.
Then radical hilar and mediastinal lymphadenectomy was
performed. Low-molecular-weight heparins calcium was in-
jected with 0.3 mL (2850 IU)/d after operation for 7 days.
RESULTS
Until August 2006, among the seven patients who
underwent lung autotransplantations, five patients had been
free of tumor recurrence for 2 to 73 months with good quality
of life. The histology and stage of the tumor was shown in
Table 2. Radioisotope scanning of the replanted lobe of one
patient revealed normal perfusion 6 years postoperatively
(Figure 2). One patient received resection of the replanted
lobe because of pulmonary vein thrombus on the second day
after transplantation, and died of respiratory failure caused by
pulmonary relapse on 15th month postoperatively. Another
patient died of brain metastases 31 months postoperatively.
No anastomotic stoma fistula occurred in these seven pa-
tients. Preoperative and postoperative pulmonary function
tests of the seven patients were performed, and the results
were shown in Table 3.
DISCUSSION
Lung cancer is the most common cause of cancer death
in men and women in many countries. NSCLC confined to
the lung is best treated with pulmonary resection, if possible.
Surgical treatment of central NSCLC is usually troublesome,
especially when the tumor invade the main bronchus and/or
pulmonary artery. Although bronchvascular double sleeve
lobectomy has already been one of the routine procedures,2,3
it cannot be performed when the centrally placed tumor
involves the bronchus and/or pulmonary artery extensively.
FIGURE 2. Radioisotope scanning of the replanted lobe (L)
and contralateral lung (R) (male patient, 6 years postopera-
tively).
TABLE 2. Histology and Stage of the Tumor
Pathologic
Stage Histology Cases
T3N2M0 Squamous cell carcinoma 3
Adeno-squamous cell carcinoma 2
T4N2M0 Squamous cell carcinoma 2
Adeno-squamous cell carcinoma 0









VC 2.08  0.18 56.0  8.0 81.3  3.8
FEV1 1.48  0.20 44.6  12.2 83.5  4.5
MVV 56.0  11.2 45.4  19.0 89.1  2.3
VC, vital capacity; FEV1, forced expiratory volume in one second; MVV, maxi-
mum voluntary ventilation.
FIGURE 1. Computed tomography scan on thorax of one
patient revealed central left lung mass.
TABLE 1. Clinical Data of the Seven Lung
Autotransplantations
Clinical Data Mean  SD
Occlusion time of pulmonary artery (min) 153.1  19.3
Ex vivo time of the replanted lobe (min) 10.7  3.5
Total operation time (min) 240.3  29.3
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The extensive sleeve resection of the bronchus and/or pul-
monary artery leaves a gap that is too large to bridge when the
lower lobe is limited by the inferior pulmonary vein. In this
condition, pneumonectomy, which has a higher surgical mor-
tality rate than lobectomy does and results in a greater loss of
functioning lung tissue, is usually performed. As we know
that some of the operative candidates with poor cardiopul-
monary function are unable to undergo pneumonectomy. And
the effect of expectant treatment of lung cancer is disap-
pointed. Under this circumstance, lung autotransplantation
may be the best surgical treatment to enable complete resec-
tion of tumor, with preservation of the distal functioning
tissue. No statistical analysis was performed in our study
because the sample of our study was too small. But our study
suggests that lung autotransplantation has similar acceptable
mortality and survival rates with bronchovascular double sleeve
lobectomy.2,3 And our study also indicates that the pulmonary
losses after autotransplantations are tiny. Lung autotransplanta-
tion is a technical demanding treatment, which should be
planned deliberately before operation. We suggest that the lung
autotransplantation technique is indicated for the treatment of
central NSCLC of the upper lobe in the patients with poor
pulmonary function that makes pneumonectomy impossible.
The patients receiving lung autotransplantations should have the
following two characteristics. The first is extended sleeve resec-
tion of the pulmonary artery and/or bronchus. The other is that
the inferior pulmonary vein limits tension-free anastomoses of
both pulmonary artery and bronchus.
How to prevent ischemia-reperfusion injury of the re-
planted lobe in lung autotransplantation is still unknown.
Zhang et al.4 reported that the temperature of flushing solu-
tion might have relation to the injury of replanted lobe. They
suggest that the solution at 19 to 23°C might help prevent
ischemia/reperfusion injury of the replanted lobe. In the study
of Spaggiari et al.5 they also concluded that the flushing
solution at 23°C could result in reduced injury of the lung.
This is an interesting finding, because low temperature, which
is essential in allotransplantation, is dispensable in lung
autotransplantation. But to our knowledge, until now there is
no study carried out to identify which flushing and preserva-
tion solution has more effective preservation of the replanted
lobe in lung autotransplantation. Some researchers1,6 sug-
gested that lung preservation solution, such as Euro-Collins
solution, might have effect on reducing ischemia/reperfusion
injury of the replanted lobe. But no further research was
carried out to prove this hypothesis. In our operations heparin
solution (12,500 U heparin/500 mL N.S.) at temperature
20°C was used to flush the lower lobe. And then the lower
lobe was subsequently immersed in the heparin solution. The
patients and the replanted lower lobes survived well after oper-
ations, which could be represented through radioisotope scan-
ning of the replanted lobe of the patient 6 years postoperatively.
This is similar to the outcome of the study of Zhang et al.4
Complications after lung autotransplantation include
pulmonary vein embolism, bleeding, narrowing of vascular
anastomosis, bronchus pleural fistula, and so on.4 The main
complication after lung autotransplantation is bronchus pleu-
ral fistula. Zhang et al.4 reported that two of four patients
suffered from bronchus pleural fistula after lung autotrans-
plantations. In our operations, bronchial anastomosis was
checked for tightness firstly, and then encircled by an inter-
costal pedicled muscle flap or abdominal omentum, which
offers good vascularity to the distal bronchus and separates it
from the pulmonary artery anastomosis. And in our seven
operations no bronchus pleural fistula was found. It may be a
good measure to reduce the incidence of this severe compli-
cation. In our study one patient suffered from pulmonary vein
thrombus and received resection of the replanted lobe on the
second day after lung autotransplantation. The factors for
pulmonary vein embolism include inadequate isolated lobar
vessel perfusion, narrowing of vein anastomosis, twisting or
compression of vessel, insufficient anticoagulation, and so
on.4 Twisting of the pulmonary vein anastomosis, which was
proved in the second day operation led to pulmonary vein
thrombus in our study. We feel that anastomosis of pulmo-
nary vein is more difficult than that of pulmonary artery and
bronchus. While performing this anastomosis we suggest
using “5-0 prolene” stitch. Sufficient anticoagulation both in
the operation and after lung autotransplantation was essential
to prevent pulmonary vein embolism. Our anticoagulation
project was safe because no severe complication, such as
secondary bleeding happened.
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